loading
전일 마감가:
$0.33
열려 있는:
$0.335
하루 거래량:
211.77K
Relative Volume:
0.62
시가총액:
$7.05M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-0.2783
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
-21.65%
1개월 성능:
-48.67%
6개월 성능:
-85.12%
1년 성능:
-83.67%
1일 변동 폭
Value
$0.32
$0.3443
1주일 범위
Value
$0.32
$0.4105
52주 변동 폭
Value
$0.32
$3.325

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
명칭
Acurx Pharmaceuticals Inc
Name
전화
917-533-1469
Name
주소
259 LIBERTY AVENUE, STATEN ISLAND
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2025-03-18
Name
최신 SEC 제출 서류
Name
ACXP's Discussions on Twitter

ACXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ACXP
Acurx Pharmaceuticals Inc
0.32 7.05M 0 -14.58M -9.80M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스

pulisher
Apr 04, 2025

Acurx Pharmaceuticals announces resale of 8.4M shares - MSN

Apr 04, 2025
pulisher
Apr 02, 2025

10 Micro-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Apr 02, 2025

Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Mar 31, 2025

ACXP stock touches 52-week low at $0.4 amid sharp annual decline - Investing.com Canada

Mar 31, 2025
pulisher
Mar 24, 2025

Acurx Pharmaceuticals Inc (ACXP) Q4 2024 Earnings Call Highlights: Advancing Antibiotic Trials ... By GuruFocus - Investing.com Canada

Mar 24, 2025
pulisher
Mar 22, 2025

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - MSN

Mar 22, 2025
pulisher
Mar 22, 2025

HC Wainwright Issues Positive Forecast for ACXP Earnings - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

FY2029 Earnings Forecast for ACXP Issued By HC Wainwright - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

HC Wainwright Reaffirms “Buy” Rating for Acurx Pharmaceuticals (NASDAQ:ACXP) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 18, 2025

Acurx Pharmaceuticals Reports 2024 Results and Advances Trials - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings call transcript: Acurx Pharmaceuticals Q4 2024 sees narrower EPS loss - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

ACXP stock touches 52-week low at $0.43 amid market challenges - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Acurx Pharmaceuticals, Inc Full Year Loss Narrows - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings Scheduled For March 18, 2025 - Benzinga

Mar 18, 2025
pulisher
Mar 17, 2025

Acurx Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 17, 2025
pulisher
Mar 14, 2025

New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP - Milton Daily Standard

Mar 14, 2025
pulisher
Mar 14, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Growth in Short Interest - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

Acurx Pharmaceuticals (ACXP) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Acurx Pharmaceuticals Announces Closing of $1.1 Million Registered Direct Offering -March 10, 2025 at 05:37 pm EDT - MarketScreener

Mar 10, 2025
pulisher
Mar 10, 2025

ACXPAcurx Pharmaceuticals Inc Latest Stock News & Market Updates - StockTitan

Mar 10, 2025
pulisher
Mar 07, 2025

Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Results - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30% - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Acurx Pharmaceuticals Launches $1.1 Million Registered Direct Offering; Shares Fall -March 07, 2025 at 10:07 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Nasdaq Gains 100 Points; US Economy Adds Fewer Jobs Than Projected - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Acurx Pharmaceuticals stock sinks on $1.1M direct offering - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering -March 07, 2025 at 08:14 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Can This $1.1M Funding Keep Acurx's Antibiotic Development on Track? - StockTitan

Mar 07, 2025
pulisher
Mar 05, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Decrease in Short Interest - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

ACXP stock touches 52-week low at $0.66 amid market challenges - Investing.com

Mar 04, 2025
pulisher
Mar 03, 2025

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Can Acurx's Antibiotic Revolutionize C. Difficile Treatment? New Microbiome Data Suggests Yes - Stock Titan

Mar 03, 2025
pulisher
Feb 28, 2025

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

What's Next for Acurx's Antibiotic Pipeline? March Earnings Call Will Reveal Development Progress - Stock Titan

Feb 28, 2025
pulisher
Feb 27, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 27, 2025
pulisher
Feb 24, 2025

Acurx’s ibezapolstat shows selective bacterial targeting By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Pharmaceuticals Advances To Phase 3 Trials For C. Difficile Infection, Stock Down - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the - Digital More

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx's ibezapolstat shows selective bacterial targeting By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx's ibezapolstat shows selective bacterial targeting - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI - Longview News-Journal

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative… - Informazione.it

Feb 24, 2025
pulisher
Feb 20, 2025

ACXP stock touches 52-week low at $0.67 amid market challenges - Investing.com UK

Feb 20, 2025
pulisher
Feb 19, 2025

Acurx Pharmaceuticals secures Japanese patent for antibiotics By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Acurx Pharmaceuticals secures Japanese patent for antibiotics - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Dual Victory for Acurx: Japanese Patent Grant Follows EMA's Green Light for Phase 3 Antibiotic Trial - StockTitan

Feb 19, 2025
pulisher
Feb 15, 2025

New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming - StreetInsider.com

Feb 15, 2025
pulisher
Feb 13, 2025

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Drops By 52.2% - Defense World

Feb 13, 2025

Acurx Pharmaceuticals Inc (ACXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):